Merg1a K+ Channel Induces Skeletal Muscle Atrophy by Activating the Ubiquitin Proteasome Pathway.
From: Department of Basic Medical Sciences, School of Veterinary Medicine, Purdue University, 625 Harrison St., West Lafayette, Indiana 47907, USA.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- Publish Date: Jul 2006
- ISSN: 1530-6860
- Volume: 20
- Issue: 9
- Pages: 1531-3
- Medium: Internet
- Language: English
- Citation (JAMA): Wang Xun, Hockerman Gregory H, Green Henry W, et al. Merg1a K+ Channel Induces Skeletal Muscle Atrophy by Activating the Ubiquitin Proteasome Pathway.. FASEB J. Jul 2006;20:1531-3
Abstract
Skeletal muscle atrophy results from an imbalance in protein degradation and protein synthesis and occurs in response to injury, various disease states, disuse, and normal aging. Current treatments for this debilitating condition are inadequate. More information about mechanisms involved in the onset and progression of muscle atrophy is necessary for development of more effective therapies. Here we show that expression of the mouse ether-a-go-go related gene (Merg1a) K+ channel is up-regulated in skeletal muscle of mice experiencing atrophy as a result of both malignant tumor expression and disuse. Further, ectopic expression of Merg1a in vivo induces atrophy in healthy wt-bearing mice, while expression of a dysfunctional Merg1a mutant suppresses atrophy in hindlimb-suspended mice. Treatment of hindlimb-suspended mice with astemizole, a known Merg1a channel blocker, inhibits atrophy in these animals. Importantly, in vivo expression of Merg1a in mouse skeletal muscle activates the ubiquitin proteasome pathway that is responsible for the majority of protein degradation that causes muscle atrophy, yet expression of a dysfunctional Merg1a mutant decreases levels of ubiquitin-proteasome proteolysis. Thus, expression of Merg1a likely initiates atrophy by activating ubiquitin-proteasome proteolysis. This gene and its product are potential targets for prevention and treatment of muscle atrophy.
Mesh Headings (Keywords): Animals, Atrophy, Brain, Esophageal Neoplasms, Ether-A-Go-Go Potassium Channels, Hindlimb, Humans, KB Cells, Mice, Muscle, Skeletal, Proteasome Endopeptidase Complex, Ubiquitin, Weight-Bearing
Check for Full Text / PubMed Unique Identifier (PMID): 16723379
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.